Biochips Market Size, Share, Trends, Growth and Forecast 2034

Biochips Market

Biochips Market By Product (DNA Chip, Protein Chip, and Lab-on-a-chip), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, and Agriculture), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, and Academic & Research Institutes) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Semiconductor & Electronics Report Format : PDF Pages: 168 Report Code: ZMR-5019 Published Date: Apr-2025 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 13.44 Billion USD 38.85 Billion 11.2% 2024

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Biochips, 2016-2025 (USD Million)
    • 2.2. Biochips: Snapshot
  • Chapter 3. Biochips - Industry Analysis
    • 3.1. Biochips: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Growing prevalence of cancer
      • 3.2.2. Increasing incidence of viral infections and immunological disorders
    • 3.3. Restraints
      • 3.3.1. High cost of biochips
      • 3.3.2. Low awareness in developing regions
    • 3.4. Opportunity
      • 3.4.1. Technological advancements
      • 3.4.2. High investment in research and development
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness
      • analysis By Application
      • 3.6.3. Market attractiveness analysis By End User
      • 3.6.4. Market attractiveness analysis by Region
  • Chapter 4. Biochips- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Biochips: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Biochips -Product Analysis
    • 5.1. Global Biochips overview: By Product type
      • 5.1.1. Global Biochips share, By Product,2018 and 2025
    • 5.2. Lab-on-a-chip
      • 5.2.1. Global Biochips by Lab-on-a-chip, 2016-2025 (USD Million)
    • 5.3. Protein Chip
      • 5.3.1. Global Biochips by Protein Chip, 2016-2025 (USD Million)
    • 5.4. DNA Chip
      • 5.4.1. Global Biochips by DNA Chip, 2016-2025 (USD Million)
    • 5.5. Resilience Training
      • 5.5.1. Global Biochips by Resilience Training, 2016-2025 (USD Million)
    • 5.6. Others
      • 5.6.1. Global Biochips by others, 2016-2025 (USD Million)
  • Chapter 6. Global Biochips -Application Analysis
    • 6.1. Global Biochips overview: By Application
      • 6.1.1. Global Biochips share, By Application, 2018 and 2025
    • 6.2. Disease Diagnostics
      • 6.2.1. Global Biochips By Disease Diagnostics, 2016-2025 (USD Million)
    • 6.3. Drug Development & Discovery
      • 6.3.1. Global Biochips By Drug Development & Discovery, 2016-2025 (USD Million)
    • 6.4. Proteomics
      • 6.4.1. Global Biochips By Proteomics, 2016-2025 (USD Million)
    • 6.5. Agriculture
      • 6.5.1. Global Biochips By Agriculture, 2016-2025 (USD Million)
    • 6.6. Genomics
      • 6.6.1. Global Biochips By Genomics, 2016-2025 (USD Million)
    • 6.7. Others
      • 6.7.1. Global Biochips by Other Applications, 2016-2025 (USD Million)
  • Chapter 7. Global Biochips -End User Analysis
    • 7.1. Global Biochips overview: By End User
      • 7.1.1. Global Biochips share, By End User, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global Biochips by Hospitals, 2016-2025 (USD Million)
    • 7.3. Diagnostics Centers
      • 7.3.1. Global Biochips by Diagnostics Centers, 2016-2025 (USD Million)
    • 7.4. Pharmaceutical & Biotechnology Companies
      • 7.4.1. Global Biochips by Pharmaceutical & Biotechnology Companies, 2016-2025 (USD Million)
    • 7.5. Research & Academic Institutes
      • 7.5.1. Global Biochips by Research & Academic Institutes, 2016-2025 (USD Million)
    • 7.6. Others
      • 7.6.1. Global Biochips by Others, 2016-2025 (USD Million)
  • Chapter 8. Global Biochips - Regional Analysis
    • 8.1. Global Biochips overview: by Region
      • 8.1.1. Global Biochips share, by Region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Biochips, 2016-2025 (USD Million)
      • 8.2.2. North America Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.2.3. North America Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.2.4. North America Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.2.5.2. The U.S. Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.2.5.3. The U.S. Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.2.6.2. Rest of North America Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.2.6.3. Rest of North America Biochips revenue, By End User, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Biochips, 2016-2025 (USD Million)
      • 8.3.2. Europe Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.3.3. Europe Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.3.4. Europe Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. U.K. Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.3.5.2. U.K. Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.3.5.3. U.K. Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.3.6.2. France Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.3.6.3. France Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.3.7.2. Germany Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.3.7.3. Germany Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.3.8.2. Rest of Europe Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.3.8.3. Rest of Europe Biochips revenue, By End User, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Biochips, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.4.3. Asia Pacific Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.4.4. Asia Pacific Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.4.5.2. China Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.4.5.3. China Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.4.6.2. Japan Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.4.6.3. Japan Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.4.7.2. India Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.4.7.3. India Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Biochips revenue, By End User, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Biochips, 2016-2025 (USD Million)
      • 8.5.2. Latin America Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.5.3. Latin America Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.5.4. Latin America Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.5.5.2. Brazil Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.5.5.3. Brazil Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.5.6.2. Rest of Latin America Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.5.6.3. Rest of Latin America Biochips revenue, By End User, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Biochips, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.6.4. The Middle East and Africa Biochips revenue, By End User, 2016-2025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Bio-Rad Laboratories, Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. bioMérieux SA
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Illumina, Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. F. Hoffmann-La Roche AG
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Thermo Fisher Scientific Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Fluidigm Corporation
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. HORIBA, Ltd.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. PerkinElmer, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. PerkinElmer, Inc.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. QIAGEN N.V.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Biochips, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Biochips attractiveness, By Product type
6. Global Biochips attractiveness, By Application
7. Global Biochips attractiveness, By End User
8. Global Biochips market share, By Product, 2018 and 2025
9. Global Biochips by Lab-on-a-chip, 2016–2025 (USD Million)
10.  Global Biochips by Protein Chip,2016–2025 (USD Million)
11.  Global Biochips by DNA Chip,2016–2025 (USD Million)
12.  Global Biochips by Others,2016–2025 (USD Million)
13.  Global Biochips share, By Application, 2018 and 2025
14. Global Biochips By Disease Diagnostics, 2016–2025 (USD Million)
15. Global Biochips By Drug Development & Discovery, 2016–2025 (USD Million)
16. Global Biochips By Proteomics, 2016–2025 (USD Million)
17.  Global Biochips By Agriculture, 2016–2025 (USD Million)
18.  Global Biochips By Genomics, 2016–2025 (USD Million)
19.  Global Biochips By Others, 2016–2025 (USD Million)
20.  Global Biochips share, By End User, 2018 and 2025
21. Global Biochips by Hospitals, 2016–2025 (USD Million)
22. Global Biochips by Diagnostics Centers, 2016–2025 (USD Million)
23.  Global Biochips by Pharmaceutical & Biotechnology Companies, 2016–2025 (USD Million)
24.  Global Biochips by Pharmaceutical & Biotechnology Companies, 2016–2025 (USD Million)
25.  Global Biochips by Others, 2016–2025 (USD Million)
26.  Global Biochips share, by Region, 2018and 2025
27.  North America Biochips, 2016–2025 (USD Million)
28.  Europe Biochips, 2016–2025 (USD Million)
29.  Asia Pacific Biochips, 2016–2025 (USD Million)
30.  Latin America Biochips, 2016–2025 (USD Million)
31.  The Middle East and Africa Biochips, 2016–2025 (USD Million)


Table Of Tables

List of Tables

1. Global Biochips: snapshot
2. Drivers of the Biochips: impact analysis
3. Restraints of the Biochips: impact analysis
4. North America Biochips revenue, By Product,2016–2025 (USD Million)
5. North America Biochips revenue, By Application, 2016–2025 (USD Million)
6. North America Biochips revenue, By End User, 2016–2025 (USD Million)
7. The U.S. Biochips revenue, By Product,2016–2025 (USD Million)
8. The U.S. Biochips revenue, By Application, 2016–2025 (USD Million)
9. The U.S. Biochips revenue, By End User, 2016–2025 (USD Million)
10. Rest of North America Biochips revenue, By Product,2016–2025 (USD Million)
11. Rest of North America Biochips revenue, By Application, 2016–2025 (USD Million)
12. Rest of North America Biochips revenue, By End User, 2016–2025 (USD Million)
13. Europe Biochips revenue, By Product,2016–2025 (USD Million)
14. Europe Biochips revenue, By Application, 2016–2025 (USD Million)
15. Europe Biochips revenue, By End User, 2016–2025 (USD Million)
16. U.K. Biochips revenue, By Product,2016–2025 (USD Million)
17. U.K. Biochips revenue, By Application, 2016–2025 (USD Million)
18. U.K. Biochips revenue, By End User, 2016–2025 (USD Million)
19. France Biochips revenue, By Product,2016–2025 (USD Million)
20. France Biochips revenue, By Application, 2016–2025 (USD Million)
21. France Biochips revenue, By End User, 2016–2025 (USD Million)
22. Germany Biochips revenue, By Product,2016–2025 (USD Million)
23. Germany Biochips revenue, By Application, 2016–2025 (USD Million)
24. Germany Biochips revenue, By End User, 2016–2025 (USD Million)
25. Rest of Europe Biochips revenue, By Product,2016–2025 (USD Million)
26. Rest of Europe Biochips revenue, By Application, 2016–2025 (USD Million)
27. Rest of Europe Biochips revenue, By End User, 2016–2025 (USD Million)
28. Asia Pacific Biochips revenue, By Product,2016–2025 (USD Million)
29. Asia Pacific Biochips revenue, By Application, 2016–2025 (USD Million)
30. Asia Pacific Biochips revenue, By End User, 2016–2025 (USD Million)
31. China Biochips revenue, By Product,2016–2025 (USD Million)
32. China Biochips revenue, By Application, 2016–2025 (USD Million)
33. China Biochips revenue, By End User, 2016–2025 (USD Million)
34. Japan Biochips revenue, By Product,2016–2025 (USD Million)
35. Japan Biochips revenue, By Application, 2016–2025 (USD Million)
36. Japan Biochips revenue, By End User, 2016–2025 (USD Million)
37. India Biochips revenue, By Product,2016–2025 (USD Million)
38. India Biochips revenue, By Application, 2016–2025 (USD Million)
39. India Biochips revenue, By End User, 2016–2025 (USD Million)
40. Rest of Asia Pacific Biochips revenue, By Product,2016–2025 (USD Million)
41. Rest of Asia Pacific Biochips revenue, By Application, 2016–2025 (USD Million)
42. Rest of Asia Pacific Biochips revenue, By End User, 2016–2025 (USD Million)
43. Latin America Biochips revenue, By Product,2016–2025 (USD Million)
44. Latin America Biochips revenue, By Application, 2016–2025 (USD Million)
45. Latin America Biochips revenue, By End User, 2016–2025 (USD Million)
46. Brazil Biochips revenue, By Product,2016–2025 (USD Million)
47. Brazil Biochips revenue, By Application, 2016–2025 (USD Million)
48. Brazil Biochips revenue, By End User, 2016–2025 (USD Million)
49. Rest of Latin America Biochips revenue, By Product,2016–2025 (USD Million)
50. Rest of Latin America Biochips revenue, By Application, 2016–2025 (USD Million)
51. Rest of Latin America Biochips revenue, By End User, 2016–2025 (USD Million)
52. The Middle East and Africa Biochips revenue, By Product,2016–2025 (USD Million)
53. The Middle East and Africa Biochips revenue, By Application, 2016–2025 (USD Million)
54. The Middle East and Africa Biochips revenue, By End User, 2016–2025 (USD Million)
 

Methodology

FrequentlyAsked Questions

The global biochips market is expected to grow due to rising demand for personalized medicine, increasing adoption in genomics and drug discovery, and advancements in lab-on-a-chip technologies.

According to a study, the global biochips market size was worth around USD 13.44 Billion in 2024 and is expected to reach USD 38.85 Billion by 2034.

The global biochips market is expected to grow at a CAGR of 11.2% during the forecast period.

North America is expected to dominate the biochips market over the forecast period.

Leading players in the global biochips market include Thermo Fisher Scientific Inc., Randox Laboratories Ltd., PerkinElmer Inc., Illumina Inc., Fluidigm Corporation, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., and bioMerieux S.A., among others.

The report explores crucial aspects of the biochips market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

Market Size And Industry AnalysisBiochip OverviewMarket Concentration CharacteristicsKey InsightsBiochip Growth DriversBiochip RestraintsBiochip ChallengesBiochip OpportunitiesBiochip SegmentationRecent DevelopmentsBiochip Regional LandscapeReport Scope Biochip Competitive LandscapeGlobal biochip market is segmented as follows:

HappyClients